pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 23·1 min read
save

Substance use disorder biotech Tempero to close after earlier 'serious' safety event

Tempero Bio, a drug developer that had big ambitions to shake up the treatment of substance use disorders, is winding down operations, Endpoints News has learned. The shutdown comes after a "serious adverse event" in ...

Apr 23, 2026·read at Endpoints ↗

April 23, 2026 02:13 PM EDTUpdated April 23, 11:06 PM PeopleStartupsR&D Sub­stance use dis­or­der biotech Tem­pero to close af­ter ear­li­er 'se­ri­ous' safe­ty event Kyle LaHucik Biotech Correspondent Tem­pero Bio, a drug de­vel­op­er that had big am­bi­tions to shake up the treat­ment of sub­stance use dis­or­ders, is wind­ing down op­er­a­tions, End­points News has … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
87 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 6h agoThe race to make new Ebola vaccines faces a cash crunchEndpoints
  • 7h agoUS-China biotech NeuShen gets $80M to develop brain-health drugsEndpoints
  • 7h agoIonis wins FDA approval of Alexander disease drug zilganersenEndpoints
  • 10h agoThiel-backed Lindus sells CRO arm in pivot to hunt for drug assetsEndpoints
  • 11h agoItaly's Menarini gets into obesity with European rights to GLP-1 from China's Gan & LeeEndpoints